T1	Intervention 54 62	BCG plus
T2	Intervention 119 157	mycobacterial and leishmanial antigens
T3	Intervention 188 211	mycobacterial (BCG; PPD
T4	Intervention 213 256	Mycobacterium leprae soluble antigen, MLSA)
T5	Intervention 261 307	leishmanial (Leishmania mexicana LV4) antigens
T6	Intervention 339 367	PPD and leishmanin skin-test
T7	Intervention 587 620	diluent control (placebo, group D
T8	Intervention 623 642	Three vaccine doses
T9	Intervention 870 902	Anti-BCG, anti-PPD and anti-MLSA
T10	Intervention 966 969	BCG
T11	Intervention 987 1017	leishmanial antigen (with BCG)
T12	Intervention 1065 1133	Mycobacterium tuberculosis/Mycobacterium bovis-related (PPD and BCG)
T13	Intervention 1143 1185	M. leprae-related (MLSA)-related, antigens
T14	Intervention 1270 1274	MLSA
T15	Intervention 1381 1419	mycobacterial and leishmanial antigens
T16	Intervention 1514 1533	leishmanial antigen
T17	Intervention 1646 1674	BCG alone and placebo groups
T18	Intervention 1778 1795	skin-test antigen
T19	Intervention 1847 1866	leishmanial antigen
T20	Intervention 1908 1927	leishmanial antigen
T21	Intervention 1973 1976	BCG
T22	Intervention 2249 2297	anti-mycobacterial or anti-leishmanial responses
T23	Intervention 2498 2536	leishmanial and mycobacterial antigens
T24	Intervention 2699 2724	anti-leishmanial response
